These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 18394603

  • 1. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
    Hernández M, Urcola JH, Vecino E.
    Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
    [Abstract] [Full Text] [Related]

  • 2. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model.
    Hong S, Kim CY, Lee WS, Shim J, Yeom HY, Seong GJ.
    Exp Eye Res; 2010 Jan; 90(1):97-103. PubMed ID: 19782071
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
    WoldeMussie E, Ruiz G, Wijono M, Wheeler LA.
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
    [Abstract] [Full Text] [Related]

  • 4. A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy.
    Ben Simon GJ, Bakalash S, Aloni E, Rosner M.
    Am J Ophthalmol; 2006 Jun; 141(6):1105-11. PubMed ID: 16765680
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J, Matragoon S, Khalifa YM, Borlongan C, Tsai NT, Caldwell RB, Liou GI.
    Ophthalmic Res; 2007 Jun; 39(2):69-75. PubMed ID: 17284931
    [Abstract] [Full Text] [Related]

  • 6. Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes.
    Thomas R, Parikh R, Muliyil J, George R, Paul P, Abraham LM.
    Indian J Ophthalmol; 2003 Jun; 51(2):123-8. PubMed ID: 12831141
    [Abstract] [Full Text] [Related]

  • 7. Reaction of Müller cells in an experimental rat model of increased intraocular pressure following timolol, latanoprost and brimonidine.
    Vidal L, Díaz F, Villena A, Moreno M, Campos JG, Pérez de Vargas I.
    Brain Res Bull; 2010 Apr 29; 82(1-2):18-24. PubMed ID: 20206241
    [Abstract] [Full Text] [Related]

  • 8. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination.
    Akman A, Cetinkaya A, Akova YA, Ertan A.
    Eye (Lond); 2005 Feb 29; 19(2):145-51. PubMed ID: 15184958
    [Abstract] [Full Text] [Related]

  • 9. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death.
    Urcola JH, Hernández M, Vecino E.
    Exp Eye Res; 2006 Aug 29; 83(2):429-37. PubMed ID: 16682027
    [Abstract] [Full Text] [Related]

  • 10. 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.
    Konstas AG, Karabatsas CH, Lallos N, Georgiadis N, Kotsimpou A, Stewart JA, Stewart WC.
    Ophthalmology; 2005 Apr 29; 112(4):603-8. PubMed ID: 15808251
    [Abstract] [Full Text] [Related]

  • 11. Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo.
    Kanamori A, Naka M, Fukuda M, Nakamura M, Negi A.
    Exp Eye Res; 2009 Mar 29; 88(3):535-41. PubMed ID: 19084521
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: a dose response in vivo study.
    Lafuente MP, Villegas-Pérez MP, Mayor S, Aguilera ME, Miralles de Imperial J, Vidal-Sanz M.
    Exp Eye Res; 2002 Feb 29; 74(2):181-9. PubMed ID: 11950228
    [Abstract] [Full Text] [Related]

  • 13. JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions.
    Huang Y, Cen LP, Choy KW, van Rooijen N, Wang N, Pang CP, Cui Q.
    Exp Eye Res; 2007 Nov 29; 85(5):684-95. PubMed ID: 17869246
    [Abstract] [Full Text] [Related]

  • 14. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE, Lai J.
    Ophthalmology; 2009 Sep 29; 116(9):1719-24. PubMed ID: 19592108
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma.
    Tsai JC, Wu L, Worgul B, Forbes M, Cao J.
    Curr Eye Res; 2005 Nov 29; 30(11):1025-31. PubMed ID: 16282136
    [Abstract] [Full Text] [Related]

  • 16. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model.
    Mittag TW, Danias J, Pohorenec G, Yuan HM, Burakgazi E, Chalmers-Redman R, Podos SM, Tatton WG.
    Invest Ophthalmol Vis Sci; 2000 Oct 29; 41(11):3451-9. PubMed ID: 11006238
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
    Ahmed FA, Hegazy K, Chaudhary P, Sharma SC.
    Brain Res; 2001 Sep 21; 913(2):133-9. PubMed ID: 11549376
    [Abstract] [Full Text] [Related]

  • 18. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
    Poinoosawmy D, Indar A, Bunce C, Garway-Heath DF, Hitchings RA.
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep 21; 240(9):721-6. PubMed ID: 12271368
    [Abstract] [Full Text] [Related]

  • 19. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
    Seki M, Tanaka T, Matsuda H, Togano T, Hashimoto K, Ueda J, Fukuchi T, Abe H.
    Br J Ophthalmol; 2005 Apr 21; 89(4):504-7. PubMed ID: 15774933
    [Abstract] [Full Text] [Related]

  • 20. An evaluation of the rate of nonresponders to latanoprost therapy.
    Rossetti L, Gandolfi S, Traverso C, Montanari P, Uva M, Manni G, Carassa R, Mastropasqua L, Quaranta L, Marchini G, Ratiglia R, Orzalesi N.
    J Glaucoma; 2006 Jun 21; 15(3):238-43. PubMed ID: 16778647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.